Teses / dissertações sobre o tema "Lung and breast/ovarian cancer"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores trabalhos (teses / dissertações) para estudos sobre o assunto "Lung and breast/ovarian cancer".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja as teses / dissertações das mais diversas áreas científicas e compile uma bibliografia correta.
Woods, Tonya M. "Extracting meaningful statistics for the characterization and classification of biological, medical, and financial data". Diss., Georgia Institute of Technology, 2015. http://hdl.handle.net/1853/53857.
Texto completo da fonteDucrot, Lucas. "Réseaux bayésiens et analyse de survie pour l’estimation de courbes de pénétrance du cancer broncho-pulmonaire lié à des prédispositions génétiques". Electronic Thesis or Diss., Sorbonne université, 2024. http://www.theses.fr/2024SORUS055.
Texto completo da fonteThis thesis focuses on estimating penetrance curves of genetic diseases from pedigree data, with a particular interest in the genetic predisposition to bronchopulmonary cancer. In this context, it aims to provide clinical and epidemiological results, as well as methodological findings.Genetic counselling is offered to patients with severe family histories of genetic diseases. Geneticists must select from these patients who should be offered genetic testing, and assess the disease risks for these patients and their families. Advances in genetics are rapid, and the number of identified pathogenic variants for different diseases increases each year. This necessitates significant predictive and risk assessment tools, especially in the context of bronchopulmonary cancer. Indeed , the links between the latter and pathogenic variants (such that SFTPA1/SFTPA2 and the genes TP53 and EGFR) are known but still poorly described.Existing methods for assessing the risk of disease occurrence rely on penetrance curves, but their estimation faces challenges due to the small number of patients and the omnipresent selection bias in genetics-collected datasets. To overcome these obstacles, the thesis explores the use of familial data, employing a set of statistical tools including Bayesian networks, mixture models, survival analysis, as well as existing models, for which it attempts to weaken certain assumptions.Chapter 1 provides an overview of the medical context of the thesis, introducing the concepts of genetic diseases and genetic counseling. Chapter 2 serves as a methodological introduction, presenting and illustrating concepts such as survival analysis, Bayesian networks, sum-product algorithm, mixture models and EM algorithm, using examples. It also offers a state-of-the-art review of penetrance curve estimation for genetic diseases and highlights the selection bias in genetics. The chapter concludes with a summary of the addressed research questions.Then, the thesis revolves around four projects. The first two projects, corresponding to chapters 3 and 4, offer predominantly clinical and epidemiological results. The first project, described in Chapter 3, compares different methods for predicting pathogenic variants for breast/ovarian cancers (Manchester Score and family models like BOADICEA). The second project, addressed in Chapter 4, provides estimates of penetrance for interstitial lung disease and bronchopulmonary cancer for carriers of pathogenic variants SFTPA1 and SFTPA2.The last two projects, corresponding to chapters 5 and 6, are more methodological. Chapter 5 is dedicated to developing a new method for estimating the penetrance curve of a genetic disease from pedigree data when the disease presents sporadic cases. It is based on an incidence constraint of the disease in the general population and a parameterization of the relative hazard between carriers and non-carriers of pathogenic variants. Chapter 6 focuses on highlighting the bias introduced by selection in genetics and its consequences on the results of the method developed in Chapter 5. Known correction methods, such as Proband's Phenotype Exclusion Likelihood (PEL) and Genotype-Restricted Likelihood (GRL), combined with our method, are applied to simulated data
Vehmanen, Paula. "Breast cancer-predisposing genes in Finnish breast and ovarian cancer families". Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/mat/bioti/vk/vehmanen/.
Texto completo da fonteFord, Deborah. "Genetic epidemiology of breast and ovarian cancer". Thesis, Institute of Cancer Research (University Of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367527.
Texto completo da fonteSchofield, Andrew C. "Molecular genetics of breast and ovarian cancer". Thesis, University of Aberdeen, 1998. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU100481.
Texto completo da fonteHuusko, P. (Pia). "Predisposing genes in hereditary breast and ovarian cancer". Doctoral thesis, University of Oulu, 1999. http://urn.fi/urn:isbn:9514254422.
Texto completo da fonteXintaropoulou, Chrysi. "Targeting aerobic glycolysis in breast and ovarian cancer". Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/29525.
Texto completo da fonteCheng, Wing-ming Edward. "Emotional well-being in Chinese lung cancer patients". Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3197157X.
Texto completo da fonteHarbord, Sara Helen Alison. "X chromosome studies and breast and ovarian carcinoma". Thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/212.
Texto completo da fonteBendrik, Christina. "Angiogenesis regulation in hormone dependent breast- and ovarian cancer". Doctoral thesis, Linköpings universitet, Institutionen för klinisk och experimentell medicin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63745.
Texto completo da fonteGorringe, Kylie Louise. "Studies of genetic instability in breast and ovarian cancer". Thesis, University of Cambridge, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.621221.
Texto completo da fonteJames, C. R. "BRCA1, a predictive biomarker in breast and ovarian cancer". Thesis, Queen's University Belfast, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.479243.
Texto completo da fonteMoraitis, Stavros. "The role of endothelins in ovarian and breast cancer". Thesis, University of Edinburgh, 1997. http://hdl.handle.net/1842/21430.
Texto completo da fonteDevamitta, Perera Muditha V. "Statistical Analysis and Modeling of Ovarian and Breast Cancer". Scholar Commons, 2017. https://scholarcommons.usf.edu/etd/7395.
Texto completo da fonteCong, Chunling. "Statistical Analysis and Modeling of Breast Cancer and Lung Cancer". Scholar Commons, 2010. http://scholarcommons.usf.edu/etd/3563.
Texto completo da fonteProbert, Adam. "The genetic epidemiology of multiple primary breast and ovarian cancer". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape10/PQDD_0024/MQ50860.pdf.
Texto completo da fonteArver, Brita. "Hereditary breast/ovarian cancer : implementation of BRCA1 & BRCA2 testing /". Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4799-6/.
Texto completo da fonteProbert, Adam. "The genetic epidemiology of multiple primary breast and ovarian cancer /". Thesis, McGill University, 1999. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=20971.
Texto completo da fonteThis was a case-control study. The cases studied were women with multiple primary breast and ovarian cancers and were identified from the Quebec Tumour Registry and a database at Sunnybrook Hospital in Toronto.
Brazil, Lucy Caroline Alexandra. "Gene Expression in High-risk Breast and Ovarian Cancer Patients". Thesis, Institute of Cancer Research (University Of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504783.
Texto completo da fonteGornall, Robert J. "TP53 polymorphisms and haplotypes in breast, cervical and ovarian cancer". Thesis, University of Southampton, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.310562.
Texto completo da fonteCho, Jaeyong. "HRPAP20 in Ovarian Cancer and Its Regulation of AP-2 in Breast Cancer". University of Cincinnati / OhioLINK, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1229809878.
Texto completo da fonteCho, Jaeyong. "HRPAP20 in Ovarian Cancer and Its Regulation of AP-2 in Breast Cancer". Cincinnati, Ohio : University of Cincinnati, 2009. http://www.ohiolink.edu/etd/view.cgi?acc_num=ucin1229809878.
Texto completo da fonteAdvisors: Arthur Buckley PhD (Committee Chair), Giovanni Pauletti PhD (Committee Member), Karen Gregerson PhD (Committee Member). Title from electronic thesis title page (viewed April 25, 2009). Includes abstract. Includes bibliographical references.
McManus, Damian Terence. "Somatic genetic and chromosomal abnormalities in ovarian and breast carcinoma". Thesis, Queen's University Belfast, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.263336.
Texto completo da fonteChudasama, Dimple. "Discovery and development of liquid biomarkers for ovarian and lung cancer". Thesis, Brunel University, 2018. http://bura.brunel.ac.uk/handle/2438/16174.
Texto completo da fonteCheng, Wing-ming Edward, e 鄭永明. "Emotional well-being in Chinese lung cancer patients". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B3197157X.
Texto completo da fonteGupta, Gaorav. "Breast cancer metastasis to the lungs : from genes to mechanisms /". Access full-text from WCMC :, 2007. http://proquest.umi.com/pqdweb?did=1456287491&sid=10&Fmt=2&clientId=8424&RQT=309&VName=PQD.
Texto completo da fonteJacobs, Christine June. "Communication about genetic testing and hereditary cancer management with breast and ovarian cancer patients". Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10046946/.
Texto completo da fonteLaunonen, V. (Virpi). "Genetic aberrations and their clinical significance in breast and ovarian cancer". Doctoral thesis, University of Oulu, 1999. http://urn.fi/urn:isbn:9514251946.
Texto completo da fonteAntoniou, A. C. "Developing a comprehensive risk model for familial breast and ovarian cancer". Thesis, University of Cambridge, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.596129.
Texto completo da fonteSingh, K. J. D. L. "Ovarian reserve testing in premenopausal recipients of chemotherapy for breast cancer". Thesis, University College London (University of London), 2008. http://discovery.ucl.ac.uk/1444394/.
Texto completo da fonteYuan, Baowen [Verfasser], e Barbara [Akademischer Betreuer] Burwinkel. "Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis / Baowen Yuan ; Betreuer: Barbara Burwinkel". Heidelberg : Universitätsbibliothek Heidelberg, 2020. http://d-nb.info/1214371698/34.
Texto completo da fonteLaidlaw, Ian James. "Xenograft studies of normal human breast epithelium transplanted to athymic nude mice". Thesis, University of Newcastle Upon Tyne, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.321307.
Texto completo da fonteWolstenholme, Jane. "Counting the costs of cancer care : breast, cervical and lung cancer in Trent". Thesis, University of Nottingham, 2001. http://eprints.nottingham.ac.uk/12097/.
Texto completo da fonte馮敬業 e King-yip Fung. "Screening of recurrent BRCA gene mutations in Chinese breast and ovarian cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31969720.
Texto completo da fonteTang, Kei-shuen, e 鄧紀旋. "Role of BRCA1 in stress-induced autophagy in breast and ovarian cancercells". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B45847204.
Texto completo da fonteFung, King-yip. "Screening of recurrent BRCA gene mutations in Chinese breast and ovarian cancer". Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B23829837.
Texto completo da fonteGrude, Lillian. "Risk Factors for Breast, Uterine and Ovarian Cancer: A competing Risks Analysis". Thesis, Norges teknisk-naturvitenskapelige universitet, Institutt for matematiske fag, 2011. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-13572.
Texto completo da fonteTomlinson, Victoria. "The putative oncogene EEF1A2 and its role in breast and ovarian cancer". Thesis, University of Edinburgh, 2007. http://hdl.handle.net/1842/25256.
Texto completo da fonteHoward, Amanda Fuchsia Star. "Women's decision making regarding hereditary breast and ovarian cancer risk-reducing strategies". Thesis, University of British Columbia, 2010. http://hdl.handle.net/2429/23498.
Texto completo da fonteMoyer, Cassandra L. "Understanding the role of BRIP1 missense variants in breast and ovarian cancer". The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1562858015936498.
Texto completo da fonteCollier, Ashley. "Integration of family health history in clinical guidelines for breast, ovarian, and colorectal cancer". University of Cincinnati / OhioLINK, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1337350837.
Texto completo da fonteProchazka, Michaela. "The risk of second primary lung carcinoma in breast cancer patients /". Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-649-2/.
Texto completo da fonteLewis, Deana L. "Angiogenic Characteristics of Tumor-Associated Dendritic Cells in Ovarian and Breast Cancer Models". Ohio University Art and Sciences Honors Theses / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=ouashonors1462296303.
Texto completo da fonteBaker, Sara Kay, e Sara Kay Baker. "Rural Arizona Nurse Practitioners' Knowledge of Hereditary Breast and Ovarian Cancer Risk Assessment". Diss., The University of Arizona, 2016. http://hdl.handle.net/10150/622972.
Texto completo da fontePatel, Shreya. "MiRNAs Trageting Proto-Oncogene C-FMS mRNA in Breast and Ovarian Cancer Cells". Thesis, The University of Arizona, 2014. http://hdl.handle.net/10150/321928.
Texto completo da fontePatel, Arpan Ajit. "ncRNA Targeting CSF-1 and CSF1R Expression in Breast and Ovarian Cancer Cells". Thesis, The University of Arizona, 2015. http://hdl.handle.net/10150/579336.
Texto completo da fonteDenton, Graeme. "Immunological recognition of the tumour related mucin MUC1". Thesis, University of Nottingham, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284052.
Texto completo da fonteSmith, Sarah Jane. "Cancer in Trent region : incidence, mortality and survival". Thesis, University of Nottingham, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312199.
Texto completo da fonteArenas, Lahuerta Enrique Javier. "Identification of novel mechanisms in human breast cancer lung metastasis and chemoresistance". Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/404730.
Texto completo da fonteEl cáncer de mama (BC, de sus siglas en inglés) es una de las mayores causas de muerte por cáncer en mujeres. El cáncer de mama es una enfermedad heterogénea, y en la heterogeneidad del tumor, las células iniciadoras tumorales (TICs, del inglés) han sido asociadas como importantes responsables en la iniciación y progresión tumoral. Basándonos en estas observaciones, nuestra hipótesis es si estas células contribuyen en la metástasis y quimioresistancia en el cáncer de mama. A través de análisis genéticos, transcriptómicos, moleculares y terapéuticos en xenoinjertos tumorales, líneas celulares y tumores humanos, en esta tesis hemos revelado en primer lugar que RARRES3, es un gen de supresión metastática en pulmón, que previene la adhesión al parénquima pulmonar y la iniciación de lesiones metastáticas, imponiendo las características de diferenciación, y cuya retención es causada por la actividad catalítica PLA1/2. Estos resultados indican que la actividad genética de RARRES3 bloquea específicamente la metástasis a pulmón y las propiedades de iniciación metastática. Además, hemos descrito una relación entre las los genes con características de autorenovación (EVI1 y SOX9) y resistencia a inhibidores de mTOR, que termina con una fenotipo más agresivo y metastático. Conjuntamente, los datos mostrados en esta tesis demuestras evidencias novedosas relacionadas con las propiedades de iniciación tumoral en distintos contextos: I) progresión y metástasis en el cáncer de mama; II) como la progresión tumoral está funcionalmente relacionada con la resistencia a inhibición de mTOR; y III) como la resistencia a terapia que está desencadenada por estas propiedades de iniciación tumoral pueden al final producir un fenotipo más agresivo y metastático
Iliopoulos, Dimitrios. "The role of the WWOX tumor suppressor in breast and lung cancer". Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1155142398.
Texto completo da fonte